openPR Logo
Press release

Salmeterol Market to face rise in demand by the end of year 2023

02-11-2019 02:35 PM CET | Health & Medicine

Press release from: Allied Market Research

Salmeterol Market

Salmeterol Market

Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist and is primarily prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. This drug is more beneficial than short-acting beta 2-agonists, such as albuterol, which has a duration of action of, for example, 4-6 hours, because it has a duration of action of 12 hours.

Drug demand is expected to increase due to an increase in people suffering from asthma and chronic obstructive pulmonary disease, low cost of medication, and the ability to maintain symptoms over a long period of time. However, certain side effects of drugs such as dizziness, sinus infection, migraine, and respiratory problems inhibit market growth.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4053

The global salmeterol market is categorized by application area and region. Depending on the application, asthma, bronchospasm and COPD are classified. By region, markets are analyzed in North America, Europe, Asia Pacific and LAMEA.

The key players operating in this market include Lupin Limited, MidasCare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., NATCO Pharma Limited, INVENT FARMA HOLDING SPAIN S.L., Mylan N.V., Redwing Pharma, and Axa Parenterals Ltd.

Key Benefits

• The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 20162023 that helps identify the upcoming market opportunities.
• Recent industry trends and developments and the future opportunities are also covered.
• Extensive knowledge about the key market players and their strategies is provided.
• Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

Salmeterol Market Key Segments:

By Application

• Asthma
• Bronchospasm
• COPD

For More Info Visit @ https://www.alliedmarketresearch.com/request-toc-and-sample/4053

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Salmeterol Market to face rise in demand by the end of year 2023 here

News-ID: 1577502 • Views: 114

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Salmeterol

Salmeterol Market Growth Set to Surge Significantly till 2025 With Prominent Key …
The research study covers the current scenario and growth prospects of the Salmeterol market (2020-2025) according to the analysis . This study includes a extensive analysis of the key segments of the industry and also the regional analysis that are taken place throughout the country. Global Salmeterol Market Overview: The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting factors, and market variations
Salmeterol Market 2019 | Worldwide Market Outlook 2025 | Major Manufacturers - L …
Salmeterol Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/82167 UpMarketResearch offers a latest published report on “Global Salmeterol Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage to clients
Salmeterol Market to Witness Huge Growth by 2025: Lupin Limited, MidasCare, Teva …
Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist, which is mostly prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. The drug has a 12-hour duration of action and thus is more beneficial than short-acting beta2- agonists, such as albuterol, which has only 4- to 6-hour duration of action. The key players operating in this market include Lupin Limited, MidasCare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline
Salmeterol Market 2019 Outlook with Top Players| Lupin Limited, MidasCare, Teva …
Overview of Salmeterol Market 2019 The objective of the study is to define Salmeterol Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial
New Report Salmeterol Market (2023): Lupin Limited, MidasCare, Teva Pharmaceutic …
Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist, which is mostly prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. The drug has a 12-hour duration of action and thus is more beneficial than short-acting beta2- agonists, such as albuterol, which has only 4- to 6-hour duration of action. Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/4053?utm_source=sank_opn_pr The increase in prevalence of people suffering from
Dry Powder Inhalers Market to Witness a Pronounce Growth During 2017 - 2025
Dry powder inhaler is a medical device that delivers formulation using the pulmonary route for systemic or local effect. The combined use of powdered formulations and device performance provides a safe, reliable, bioequivalent, and efficient method of drug delivery into the lungs. The device performance depends upon the air inlet size, impaction angle of the powder, mouthpiece length, grid structure, and mouth piece configuration. Some of the Food and Drug